VIVA and VEINS 2023: Late-Breaking Video Collection
Published: 27 November 2023
-
Views:
485
-
Likes:
7
-
Views:
485
-
Likes:
7
-
Up Next -
10m 41sPart 1 | Session 5 STRIKE-PE: Indigo Aspiration System for PE -
6m 40sPart 1 | Session 6 PROMISE II: 12M Results From Pivotal Trial of LimFlow System
-
4m 2sPart 1 | Session 1 SAVER: Gender Subgroup Analysis Marianne Brodmann
-
7m 2sPart 1 | Session 2 VIVID: Venous Stent for the Iliofemoral Vein Mahmood K Razavi
-
5m 10sPart 1 | Session 3 DETOUR 1 and DETOUR2: PQ Bypass System for Percutaneous Femoropopliteal Bypass Sean Lyden
Overview
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
About the episode
VIVA 23 - We are joined by Dr Mahmood Razavi (St. Joseph Heart & Vascular Center, Orange, CA, US) to discuss the findings from an early feasibility study of non-invasive therapeutic ultrasound (TUS) to treat chronic limb-threatening ischemia.
12 patients were enrolled in the trial, who had Rutherford class 3, 4 or 5 peripheral arterial disease. Participants received 30-40 TUS treatment sessions over two months.
Findings suggested that the therapy was tolerable and acceptable to patients. A 17% improvement in tissue oxygenation was also observed.
Interview Questions:
- What are the unmet needs of PAD patients in 2023?
- What was the patient population and study design?
- What are the key findings?
- What are your take-home messages?
Recorded remotely from Orange, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent
Comments